LO Buyout Rumors Persists; Deal Has Challenges

04/30/14 02:18PM EDT

LO is up nearly 3% intraday after closing up 4% yesterday (and hitting all-time highs) – we believe rumors that RAI is interested in acquiring LO are responsible for the move, however we think a hypothetical deal (especially an imminent one) is challenged:

  • Our main flag is that a combined RAI + LO would own ~ 67% of U.S. menthol market, which we believe should trigger anti-trust flags.
  • Big tobacco is already a highly concentrated industry in the U.S. across the big three – MO has a leading ~51% of market share; a combined RAI + LO would equate to ~ 42% share.   

RAI could look to divest such menthol brands as Kool, Winston and Salem (~5% total market share), which could serve to change the consideration of the FTC/DOJ.

We’re not surprised to hear rumors that LO is a take-out target. Underling our Best Idea Long Call on Lorillard in early March 4th was the strength of its portfolio:

  • Leading share and profitability of its core menthol business,
  • Our belief in the limited menthol regulatory risk over the longer term (substantiated by a Washington, D.C. tobacco expert), and
  • Upside growth in its blu e-cigarette business that commands leading share in the U.S.

As part of the Best Idea’s thesis we did not consider a RAI + LO deal. We think the recent announcement that Susan Cameron will replace Daan Delen on May 1 could also be fueling speculation that she wants to come out of the box “strong” – which is drumming up rumors about this deal. 

There’s been no comment from either LO or RAI.  Even without consideration of a deal with RAI, we’ve outlined a scenario in which LO’s business propels the stock to $80/share over the longer term. That would be ~ 36% higher than today’s price.

Howard Penney

Managing Director

Matt Hedrick

Associate

Fred Masotta

Analyst

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.